Amarin Corp. Plc (AMRN)
13.77
-0.08
(-0.54%)
USD |
NASDAQ |
Sep 02, 14:38
Amarin Net Income (TTM) : -27.07M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.07M |
| March 31, 2026 | -33.72M |
| December 31, 2025 | -38.98M |
| September 30, 2025 | -85.93M |
| June 30, 2025 | -103.63M |
| March 31, 2025 | -87.79M |
| December 31, 2024 | -81.98M |
| September 30, 2024 | -39.65M |
| June 30, 2024 | -33.45M |
| March 31, 2024 | -52.59M |
| December 31, 2023 | -59.26M |
| September 30, 2023 | -52.56M |
| June 30, 2023 | -38.46M |
| March 31, 2023 | -90.19M |
| December 31, 2022 | -104.96M |
| September 30, 2022 | -91.11M |
| June 30, 2022 | -99.11M |
| March 31, 2022 | -21.97M |
| December 31, 2021 | 7.785M |
| September 30, 2021 | -1.963M |
| June 30, 2021 | 4.219M |
| March 31, 2021 | 0.8524M |
| December 31, 2020 | -18.08M |
| September 30, 2020 | -15.89M |
| June 30, 2020 | -12.42M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.65M |
| December 31, 2019 | -22.78M |
| September 30, 2019 | -63.33M |
| June 30, 2019 | -84.40M |
| March 31, 2019 | -116.38M |
| December 31, 2018 | -115.94M |
| September 30, 2018 | -105.33M |
| June 30, 2018 | -91.71M |
| March 31, 2018 | -71.83M |
| December 31, 2017 | -67.60M |
| September 30, 2017 | -69.86M |
| June 30, 2017 | -73.50M |
| March 31, 2017 | -72.37M |
| December 31, 2016 | -80.31M |
| September 30, 2016 | -77.05M |
| June 30, 2016 | -93.04M |
| March 31, 2016 | -111.16M |
| December 31, 2015 | -112.32M |
| September 30, 2015 | -110.12M |
| June 30, 2015 | -105.77M |
| March 31, 2015 | -58.88M |
| December 31, 2014 | -56.89M |
| September 30, 2014 | -52.89M |
| June 30, 2014 | -75.45M |
| March 31, 2014 | -130.24M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 705.50M |
| Alkermes Plc | 66.12M |
| Cellectis SA | -65.33M |
| Akari Therapeutics Plc | -30.90M |
| Liquidia Corp. | 138.61M |